Cargando…
Potent and Targeted Activation of Latent HIV-1 Using the CRISPR/dCas9 Activator Complex
HIV-1 provirus integration results in a persistent latently infected reservoir that is recalcitrant to combined antiretroviral therapy (cART) with lifelong treatment being the only option. The “shock and kill” strategy aims to eradicate latent HIV by reactivating proviral gene expression in the cont...
Autores principales: | Saayman, Sheena M, Lazar, Daniel C, Scott, Tristan A, Hart, Jonathan R, Takahashi, Mayumi, Burnett, John C, Planelles, Vicente, Morris, Kevin V, Weinberg, Marc S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4786915/ https://www.ncbi.nlm.nih.gov/pubmed/26581162 http://dx.doi.org/10.1038/mt.2015.202 |
Ejemplares similares
-
Activating PTEN Tumor Suppressor Expression with the CRISPR/dCas9 System
por: Moses, Colette, et al.
Publicado: (2018) -
On-target activity predictions enable improved CRISPR–dCas9 screens in bacteria
por: Calvo-Villamañán, Alicia, et al.
Publicado: (2020) -
Functional Comparison between VP64-dCas9-VP64 and dCas9-VP192 CRISPR Activators in Human Embryonic Kidney Cells
por: Javaid, Nasir, et al.
Publicado: (2021) -
Detection of CRISPR-dCas9 on DNA with Solid-State
Nanopores
por: Yang, Wayne, et al.
Publicado: (2018) -
The PROTECTOR strategy employs dCas orthologs to sterically shield off-target sites from CRISPR/Cas activity
por: Sapozhnikov, Daniel M., et al.
Publicado: (2023)